Law favours slaughtering animals for food: SDPI reminds BJP

Bengaluru, Apr 10: With 10 new COVID-19 cases, Karnataka's tally of coronavirus cases has climbed to 207, the Karnataka government has said.

The 207 COVID-19 cases include 30 discharged and 6 deaths. Out of 10 new cases, 9 are close contacts of people who had earlier tested positive for coronavirus.

"10 more COVID-19 positive cases reported in Karnataka, taking the total number of positive cases in the state to 207, including 6 deaths and 30 discharged. 9 of the 10 new cases, are close contacts of people who had tested positive for the virus earlier," said the Karnataka government.

Meanwhile, the State Department of Health and Family Welfare has further notified 14 more COVID-19 dedicated hospitals in the state.

These hospitals include Bagalkot District Hospital, Chamarajanagar Institute of Medical Sciences, District Hospital Chikkaballapur, SNR District Hospital, Kandaya Bhavan Ramanagar, Tumkur District Hospital, Karwar Institute of Medical Sciences Uttara Kannada, Vijayapura District Hospital and Yadgiri District Hospital.

India's total number of coronavirus positive cases rose to 6,412 on Friday.

Out of the total cases, 5,709 are active patients and 503 of them have been cured/discharged, as per the Ministry of Health and Family Welfare.

With 30 new deaths reported in the last 12 hours, the toll stands at 199.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jan 10: Demanding the setting up of a House Committee to probe the Mangaluru violence, former Chief Minister HD Kumaraswamy on Friday released multiple videos of the clashes that broke out during the anti-Citizenship Amendment Act protest that claimed two lives on December 19.

Janata Dal-Secular leader further demanded suspension of Police Commissioner PS Harsha and insisted that House Committee consisting of members of all the parties should be formed to probe into Mangaluru violence and said that magisterial inquiry ordered by the state government cannot be trusted.

"Constitute a House committee and produce the fact. The main culprit is the commissioner of Mangaluru, remove the officer as he is the main culprit. I am going to take this issue on the floor of the House." Kumaraswamy said during a press conference here.

Two people were killed in Mangaluru in the alleged police firing after protests against the Citizenship Amendment Act turned violent.

The Act grants Indian citizenship to refugees from Hindu, Christian, Sikh, Buddhist and Parsi communities fleeing religious persecution from Pakistan, Afghanistan, and Bangladesh who entered India on or before 31, 2014.